Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets.
Julia FeigeTobias MoserKatja AkgünKerstin SchwenkerWolfgang HitzlElisabeth Haschke-BecherTjalf ZiemssenJohann SellnerPublished in: Annals of clinical and translational neurology (2024)
Peripheral immune cell profiling revealed more differentiated insights into the prompt and delayed immunological effects of repeated intravenous anti-CD20 treatment. The observation of proportional changes of some pathogenetically relevant immune cell subsets only after two infusion cycles deserves further attention.